Rosen's Breast Pathology, 4e

932

Chapter 33

110. Ooe A, Takahara S, Sumiyoshi K, et al. Preoperative diagnosis of duc­ tal carcinoma in situ arising within a mammary fibroadenoma: a case report. Jpn J Clin Oncol 2011;41:918–923. 111. Petersson F, Tan PH, Putti TC. Low-grade ductal carcinoma in situ and invasive mammary carcinoma with columnar cell morphology arising in a complex fibroadenoma in continuity with columnar cell change and flat epithelial atypia. Int J Surg Pathol 2010;18:352–357. 112. Goldman RL, Friedman NB. Carcinoma of the breast arising in fibroadenomas, with emphasis on lobular carcinoma. Cancer 1969;23:544–550. 113. Gittleman MA, Horstmann JP. Cystosarcoma phyllodes with concur­ rent infiltrating ductal carcinoma. Breast 1983;9:15–17. 114. Grimes MM. Cystosarcoma phyllodes of the breast: histologic fea­ tures, flow cytometry analysis, and clinical correlations. Mod Pathol 1992;5:232–239. 115. Quinlan-Davidson S, Hodgson N, Elavathil L, et al. Borderline phyllodes tumor with an incidental invasive tubular carcinoma and lobular carci­ noma in situ component: a case report . J Breast Cancer 2011;14:237–240. 116. Nomura M, Inoue Y, Fujita S, et al. A case of noninvasive ductal carcinoma arising in malignant phyllodes tumor. Breast Cancer 2006;13:89–94. 117. Kuo YJ, Ho DM, Tsai YF, et al. Invasive ductal carcinoma arising in phyllodes tumor with isolated tumor cells in sentinel lymph node. J Chin Med Assoc 2010;73:602–604. 118. Korula A, Varghese J, Thomas M, et al. Malignant phyllodes tumour with intraductal and invasive carcinoma and lymph node metastasis. Singapore Med J 2008;49:e318–e21. 119. Hayes BD, Quinn CM. Microinvasive lobular carcinoma arising in a fibroadenoma. Int J Surg Pathol 2013;21:419–421. 120. Kefeli M, Yildiz L, Akpolat I, et al. The coexistence of invasive duc­ tal carcinoma and malignant phyllodes tumor with liposarcomatous and chondrosarcomatous differentiation in the same breast in a post- osteosarcoma case. Pathol Res Pract 2008;204:919–923. 121. Abdul Aziz M, Sullivan F, Kerin MJ, et al. Malignant phyllodes tumour with liposarcomatous differentiation, invasive tubular carcinoma, and ductal and lobular carcinoma in situ : case report and review of the literature. Pathol Res Int 2010; 2010:501274. 122. Klausner JM, Lelcuk S, Ilia B, et al. Breast carcinoma originating in cystosarcoma phyllodes. Clin Oncol 1983;9:71–74. 123. LeonAS-Y,MeredithDJ.Tubularcarcinomadevelopingwithinarecur­ ring cystosarcoma phyllodes of the breast. Cancer 1980;46:1863–1867. 124. Knudsen PJ, Ostergaard J. Cystosarcoma phyllodes with lobular and ductal carcinoma in situ . Arch Pathol Lab Med 1987;111:873–875. 125. Ramdass MJ, Dindyal S. Phyllodes breast tumour showing invasive squamous-cell carcinoma with invasive ductal, clear-cell, secretory, and squamous components. Lancet Oncol 2006;7:880. 126. Huntrakoon M. Malignant cystosarcoma phyllodes with simultaneous carcinoma in the ipsilateral breast. S Med J 1984;77:1176–1178. 127. Padmanabhan V, Dahlstrom JE, Chong GC, et al. Phyllodes tumor with lobular carcinoma in situ and liposarcomatous stroma. Pathology 1997;29:224–226. 128. Macher-Goeppinger S, Marme F, Goeppert B, et al. Invasive ductal breast cancer within a malignant phyllodes tumor: case report and ­assessment of clonality. Hum Pathol 2010;41:293–296. Occult Carcinoma Presenting with Axillary Lymph Node Metastases 129. Baron PL, Moore MP, Kinne DW, et al. Occult breast cancer pre­ senting with axillary metastases: updated management. Arch Surg 1990;125:210–215. 130. Fitts WT Jr, Steiner GC, Enterline HT. Prognosis of occult carcinoma of the breast. Am J Surg 1963;106:460–463. 131. Ashikari R, Rosen PP, Urban JA, et al. Breast cancer presenting as an axillary mass. Ann Surg 1976;183:415–417. 132. Campana F, Fourquet A, Ashby MA, et al. Presentation of axillary lymphadenopathy without detectable breast primary (T0N1b breast cancer): experience at Institut Curie. Radiother Oncol 1989;15:321–325. 133. Haupt HM, Rosen PP, Kinne DW. Breast carcinoma presenting with axillary lymph node metastases. An analysis of specific histopatho­ logic features. Am J Surg Pathol 1985;9:165–175. 134. Patel J, Nemoto T, Rosner D, et al. Axillary lymph node metastasis from an occult breast cancer. Cancer 1981;47:2923–2927.

135. Rosen PP, Kimmel M. Occult breast carcinoma presenting with axil­ lary lymph node metastases: a follow-up study of 48 patients. Hum Pathol 1990;21:518–523. 136. Buchanan CL, Morris EA, Dorn PL, et al. Utility of breast magnetic resonance imaging in patients with occult primary breast cancer. Ann Surg Oncol 2005;12:1045–1053. 137. Ellerbroek N, Holmes F, Singletary E, et al. Treatment of patients with isolated axillary nodal metastases from an occult primary carcinoma consistent with breast origin. Cancer 1990;66:1461–1467. 138. Merson M, Andreola S, Galimberti V, et al. Breast carcinoma present­ ing as axillary metastases without evidence of a primary tumor. Cancer 1992;70:504–508. 139. Lanitis S, Behranwala KA, Al-Mufti R, et al. Axillary metastatic dis­ ease as presentation of occult or contralateral breast cancer. Breast 2009;18:225–227. 140. Westbrook KC, Gallager HS. Breast carcinoma presenting as an axil­ lary mass. Am J Surg 1971;122:607–611. 141. Rosen EL, Sickles E, Keating D. Ability of mammography to reveal nonpalpable breast cancer in women with palpable breast masses. AJR Am J Roentgenol 1999;172:309–312. 142. Marcantonio DR, Libshitz HI. Axillary lymph node metastases of bronchogenic carcinoma. Cancer 1995;76:803–806. 143. Tartter PI, Weiss S, Ahmed S, et al. Mammographically occult breast cancers. Breast J 1999;5:22–35. 144. Vilcoq JR, Calle R, Ferme F, et al. Conservative treatment of axil­ lary adenopathy due to probable subclinical breast cancer. Arch Surg 1982;117:1136–1138. 145. Jackson B, Scott-Conner C, Moulder J. Axillary metastasis from occult breast carcinoma: diagnosis and management. Am Surg 1995;61:431–434. 146. Dunnington GL, Pearce J, Sherrod A, et al. Breast carcinoma present­ ing as mammographic microcalcifications in axillary lymph nodes. Breast Dis 1995;8:193–198. 147. Helvie MA, Rebner M, Sickles EA, et al. Calcifications in meta­ static breast carcinoma in axillary lymph nodes. Am J Radiol 1988;151:921–922. 148. Sardanelli F, Boetes C, Borisch B, et al. Magnetic resonance imaging of the breast: recommendations from the EUSOMA working group. Eur J Cancer 2010;46:1296–1316. 149. de Bresser J, de Vos B, van der Ent F, et al. Breast MRI in clinically and mammographically occult breast cancer presenting with an axillary metastasis: a systematic review. Eur J Surg Oncol 2010;36:114–119. 150. Lieberman S, Sella T, Maly B, et al. Breast magnetic resonance imag­ ing characteristics in women with occult primary breast carcinoma. Isr Med Assoc J 2008;10:448–152. 151. Lu H, Xu YL, Zhang SP, et al. Breast magnetic resonance imaging in patients with occult breast carcinoma: evaluation on feasibility and correlation with histopathological findings. Chin Med J (Engl) 2011;124:1790–1795. 152. Jaffer S, Goldfarb AB, Gold JE, et al. Contralateral axillary lymph node metastasis as the first evidence of locally recurrent breast carcinoma. Cancer 1995;75:2875–2878. 153. Devitt JE, Michalchuk AW. Significance of contralateral axillary me­ tastases in carcinoma of the breast. Can J Surg 1969;12:178–180. 154. Breslow A. Occult carcinoma of second breast following mastectomy. JAMA 1973;226:1000–1001. 155. Huston TL, Pressman PI, Moore A, et al. The presentation of contra­ lateral axillary lymph node metastases from breast carcinoma: a clini­ cal management dilemma. Breast J 2007;13:158–164. 156. Noguchi S, Motomura K, Inaji H, et al. Differentiation of pri­ mary and secondary breast cancer with clonal analysis. Surgery 1994;115:458–462. 157. Pandis N, Teixeira MR, Gerdes A-M,et al. Chromosome abnormali­ ties in bilateral breast carcinomas. Cytogenetic evaluation of the clonal origin of multiple primary tumors. Cancer 1995;76:250–258. 158. Axelsson J, Andersson A. Cancer of the male breast. World J Surg 1983;7:281–287. 159. Balish SM, Khandekhar JD, Sener SF. Cancer of the male breast pre­ senting as an axillary mass. J Surg Oncol 1993;53:68–70. 160. Yap HY, Tashima CK, Blumenschein GR, et al. Male breast ­carcinoma—a natural history study. Cancer 1979;44:748–754. 161. Kemeny MM, Rivera DE, Terz JJ, et al. Occult primary adenocarci­ noma with axillary metastases. Am J Surg 1986;152:43–47.